A detailed history of Advantage Trust CO transactions in Johnson & Johnson stock. As of the latest transaction made, Advantage Trust CO holds 751 shares of JNJ stock, worth $116,705. This represents 0.08% of its overall portfolio holdings.

Number of Shares
751
Previous 782 3.96%
Holding current value
$116,705
Previous $114 Million 6.48%
% of portfolio
0.08%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $4,509 - $5,188
-31 Reduced 3.96%
751 $122 Million
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $31,044 - $32,548
-200 Reduced 20.37%
782 $124 Million
Q4 2023

Feb 07, 2024

BUY
$145.6 - $158.88 $142,979 - $156,020
982 New
982 $154 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Advantage Trust CO Portfolio

Follow Advantage Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Trust CO with notifications on news.